Details of the Drug

General Information of Drug (ID: DM5YXGL)

Drug Name

HB-AdMSC

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04362189) Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19. U.S. National Institutes of Health.